UPMC, General Catalyst, Northwell: 16 digital health investments in January
The Institute for Exposomic Research, Mount Sinai’s precision exposome medicine company, launches LinusBio. LinusBio uses patient blood samples to discover novel biomarkers for diseases and disorders such as autism spectrum disorder, amyotrophic lateral sclerosis (Lou Gehrig's disease), and some cancers.